How Athletes Should Test, Dose, and Retest Vitamin D

Most vitamin D failure looks the same. An athlete takes 1,000 IU per day for years, never retests, then turns up below 25 ng/mL on a winter blood draw with a stress fracture, an upper-respiratory cold that will not clear, or training that feels heavier than the numbers say it should. The dose was the problem. 1,000 IU is roughly a third of the maintenance dose in a lifter with normal body fat and roughly a fifth of the corrective dose once adiposity is in the picture.

What works is a status target, a dose adjusted for body composition, and a retest cadence built around the seasonal trough.

0125(OH)D is the test that decides everything

Vitamin D circulates in two forms after intake. Cholecalciferol from sunlight or supplements is the precursor. The liver hydroxylates it to 25-hydroxyvitamin D, which is the storage form and the half-life-defining pool. The kidney then converts a small fraction to 1,25-dihydroxyvitamin D, the active hormone that binds the vitamin D receptor.¹

The trap is ordering 1,25(OH)2D as a status check. The body defends 1,25(OH)2D aggressively under deficiency by upregulating renal 1-alpha-hydroxylase, so the active form can read normal or even high in an athlete who is functionally deficient. 25(OH)D has a half-life of roughly 2 to 3 weeks and reflects substrate availability across the prior month or two, which is the variable that status decisions actually depend on.³

Order 25(OH)D total. Some labs split D2 and D3, which matters mostly for athletes who supplement with cholecalciferol (D3). The total number is the one that matches the threshold literature.

02The thresholds that matter, and the disagreement among them

Three sources dominate the threshold conversation, and they do not agree.

The IOM threshold is built for population public-health policy and is conservative for an athlete making a supplementation decision.² The 2011 Endocrine Society guideline used a higher clinical-risk threshold, while the 2024 prevention guideline no longer endorses a universal 30 ng/mL target for generally healthy adults.³²⁴ The practical athlete read still works inside a 30 to 50 ng/mL band because the upside is clearest when low status is corrected and the benefit signal flattens once an athlete is already replete.¹¹¹⁹

A more practical reading.

03Adiposity changes the dose more than people realize

This is the lever almost no one adjusts for. Vitamin D is fat-soluble, and adipose tissue acts as a slow reservoir that pulls cholecalciferol out of plasma. A reader at 30 percent body fat absorbs the same dose, distributes more of it into adipose, and releases less into circulation than a leaner person on the same milligrams.

Wortsman and colleagues showed in 2000 that adults with obesity had lower circulating parent vitamin D after UVB exposure and oral vitamin D2 dosing, and the gap tracked body fat percentage rather than weight per se.⁴ Drincic and colleagues in 2012 tested a different framing. They estimated that the inverse relationship between body weight and 25(OH)D status is best explained by simple volumetric distribution of cholecalciferol through total body mass, with adipose acting as a large dilution compartment rather than a hard sequestration trap.⁵ Ekwaru and colleagues in 2014 ran dose-response analyses in over 17,000 supplement users and found that participants with obesity needed two to three times the dose of normal-weight participants to reach the same serum 25(OH)D.⁶

The practical adjustment.

A related corollary. Substantial fat loss can modestly raise 25(OH)D in some people without any change in dose. The storage compartment shrinks, so the same intake distributes through a smaller adipose volume. Retest before increasing the dose.

04What the performance evidence actually shows

The vitamin D performance literature is messier than the supplement industry suggests. The strongest signal sits in three places: bone, immune function, and skeletal-muscle performance in genuinely deficient populations.

Bone is the cleanest. Ruohola and colleagues followed Finnish military recruits through basic training and found that men below the median 25(OH)D level had roughly 3.6 times the stress-fracture odds of men above the median.⁸ Tenforde and colleagues add the athlete context: in adolescent girls, prior fracture, BMI below 19, late menarche, and prior gymnastics or dance history were independent stress-fracture risk factors.⁷ Read vitamin D beside the rest of the bone-risk picture, not as a lone lab value.

Immune signal is real and modest. Martineau and colleagues published an individual-participant-data meta-analysis of 25 RCTs in 2017 showing that daily or weekly vitamin D reduced acute respiratory infections, with the largest effect concentrated in people with baseline 25(OH)D below 25 nmol/L (about 10 ng/mL).¹⁰ The benefit comes from correcting low status. Adding vitamin D to an already-replete athlete does very little.

Performance evidence is mixed, and the signal is still promising in the right athlete. Close and colleagues supplemented UK athletes with 5,000 IU/day for 8 weeks, raised winter 25(OH)D, and reported improvements in 10 m sprint and vertical jump in a small trial.⁹ A separate Close dose-response trial raised 25(OH)D with 20,000 or 40,000 IU/week, but did not improve bench press, leg press, or vertical jump over 12 weeks.²¹ Backx and colleagues showed that 2,200 IU/day corrected deficient or insufficient status in most Dutch elite athletes within 3 months, but that study tested vitamin D status rather than performance outcomes.¹² Owens and colleagues reviewed the athlete literature and reached the useful coaching conclusion: vitamin D is a biological requirement first, and a promising performance lever mainly when an athlete is correcting low status.¹¹

Treat vitamin D as a corrective intervention. Effect size scales with the size of the gap it is closing.

05Athletic populations that test low more often

A handful of profiles repeat in the screening data and vitamin D physiology literature, and they predict who needs supplementation in the first place.¹¹²⁶

The most underrated subset is the last one. Athletes who train outdoors year-round but mostly before sunrise or after sundown look like they should be replete. Time of day changes UVB exposure, so blood work is the clean way to know.²⁶

06The dose-response math you can plan around

Heaney and colleagues in 2003 established the most useful rule of thumb. In healthy adults, 1,000 IU of cholecalciferol per day often raises serum 25(OH)D by approximately 6 to 7 ng/mL over 8 to 12 weeks at steady state, with substantial variation by body weight, baseline status, adherence, season, and genetics in vitamin D-binding protein.¹³ The relationship is usable for planning at ordinary supplemental doses and becomes less predictable as dose rises.

Four practical lanes for athletes.

Two cautions sit on top of these numbers. First, response varies by genetic factors in vitamin D-binding protein and the vitamin D receptor. Some adults are slow responders and need more dose and more time before the lab moves. Second, monthly megadose protocols deserve to be retired. Sanders and colleagues randomized older women to a single annual 500,000 IU dose or placebo in 2010 and found a 26 percent increase in falls and a 26 percent increase in fractures in the high-dose group.¹⁴ Bischoff-Ferrari and colleagues in 2016 compared 24,000 IU monthly, 60,000 IU monthly, and 24,000 IU plus calcifediol monthly in older adults and found increased fall risk in the higher monthly doses despite higher 25(OH)D.¹⁵ For athletes, daily or weekly dosing is easier to titrate and better matched to retesting.

07Cofactors that actually matter

The cofactor list has three real entries and a long list of marketing-driven additions.

Magnesium is required for the hepatic 25-hydroxylase and renal 1-alpha-hydroxylase that activate vitamin D. Reviews and randomized trial data show that magnesium status can influence vitamin D metabolism, and 48 percent of Americans ingest less magnesium from food and beverages than their respective EARs.²²²³²⁵ Anyone running a vitamin D protocol should make magnesium intake boringly adequate first. The form, dose, and timing playbook is in Magnesium for Sleep, Cramps, and Recovery.

Vitamin K helps activate vitamin K-dependent proteins involved in bone metabolism and calcium handling. People taking warfarin or similar anticoagulants need consistent vitamin K intake rather than casual changes from supplements.²⁷

Calcium adequacy matters because vitamin D's bone-mineral job depends on it. The RDA is roughly 1,000 mg/day from food for most adults.² Dairy, leafy greens, sardines, tofu, and fortified plant milks are the practical floor. Athletes running vitamin D repletion while undereating calcium are leaving the main bone-health pathway underfed.

Preformed vitamin A (retinol) deserves attention when someone is stacking supplements. Fish liver oils contain vitamin D and can also contribute preformed vitamin A.²⁸ Use a plain D3 supplement when you want predictable dosing.

Zinc, boron, and the long tail of supplement-stack additions are not load-bearing for vitamin D status. Skip them.

One absorption detail can raise the response from the same dose by about half. Mulligan and Licata showed that taking vitamin D with the largest meal of the day raised serum 25(OH)D by about 50 percent over two to three months compared to taking it on an empty stomach or with a light breakfast.²⁰ Dietary fat at the same meal is the operative variable.

08Testing cadence and what to retest

The pattern that fails is one annual lab in spring, drawn at the climbing edge of the seasonal curve.

Retest at least 8 weeks after a dose change. Earlier draws catch the wrong slope. Aim the late-winter draw at the same calendar week each year so the seasonal comparison stays clean.

09The bigger-is-better trap

The temptation when an athlete reads 28 ng/mL is to push to 80. The evidence does not support that move. Above 50 ng/mL the bone, immune, and muscle benefit signal flattens, and the toxicity tail begins.

The VITAL trial randomized 25,871 adults to 2,000 IU/day vitamin D or placebo for a median 5.3 years. There was no reduction in invasive cancer, cardiovascular events, or all-cause mortality. The cohort's mean baseline 25(OH)D was about 31 ng/mL.¹⁶ The DO-HEALTH trial in 2,157 relatively healthy European adults aged 70 plus tested 2,000 IU/day vitamin D3 in a factorial design and found no significant improvement in blood pressure, infection rate, physical performance, cognition, or nonvertebral fractures over three years.¹⁷

The Mendelian randomization data tell a related story. Brøndum-Jacobsen and colleagues used genetic variants associated with lower 25(OH)D to estimate causal effects on cardiovascular disease and showed much smaller effects than the observational literature had implied.¹⁸ Most of the apparent benefit of high vitamin D status in observational data was probably confounding by sun exposure, fitness, and other health behaviors that travel with outdoor time.

The verdict from VITAL, DO-HEALTH, and the Mendelian randomization work is consistent. Vitamin D supplementation in already-replete adults does very little. Correcting deficiency is where the action is: bone health is the strongest target, respiratory-infection benefits are strongest in people starting very low, and athlete performance remains most promising when low status is corrected.

Toxicity is rare and worth taking seriously. It is usually supplement-driven and marked by hypercalcemia, hypercalciuria, and very high 25(OH)D, typically above about 150 ng/mL. Severe cases can involve kidney stones, renal failure, and soft-tissue or coronary calcification. Case reports cluster around self-prescribed megadose protocols, often 50,000 IU per day for weeks. The IOM adult Tolerable Upper Intake Level is 4,000 IU/day, which should be treated as a safety ceiling rather than a target.²

10A simple operating playbook

The protocol most athletes do not run, and should.

1. Order 25(OH)D total before changing anything. Do not guess by symptoms.
2. Read the number against the 30 to 50 ng/mL operating band. That is the band where the bone, immune, and performance signals cluster.
3. If below 30, calculate a corrective dose against your body composition. Roughly 1,000 IU/day for every 6 to 7 ng/mL of expected rise in a normal-weight adult, more if BMI is above 25.
4. Confirm magnesium intake reaches the EAR. 265 mg/day for women, 350 mg/day for men, from food or supplementation. The vitamin D protocol is easier to correct when magnesium intake is already adequate.
5. Take vitamin D with the meal that contains the most fat. Absorption improves meaningfully compared to a fat-free or low-fat meal, with one clinical report showing about a 50 percent higher 25(OH)D response.
6. Retest at 8 to 12 weeks. Adjust dose by the response curve, not by feel.
7. Reset cadence to twice yearly once status is stable. Late-winter trough and late-summer peak.
8. Avoid annual megadose protocols, especially in older adults. For athletes, daily or weekly dosing is easier to titrate against retesting than intermittent megadosing.

The common version of vitamin D failure comes down to skipping the lab work. Athletes who run a twice-yearly loop find that 25(OH)D becomes a trend they can plan against. Athletes who guess at dose and skip retesting accumulate quiet deficits that show up in bones, sleep, and the recovery numbers a watch cannot see.